Has chemotherapy anywhere to go?

The methods used in the past to detect anticancer agents should be replaced by new approaches, where the aim is specifically to find treatments for the common solid cancers. Programmes have now been introduced which allow the rapid preclinical development and clinical trial of new classes of chemical. Provided sensitive markers of tumour response can be developed, new types of anticancer agent with activity against solid cancer should be discovered.